Status:
COMPLETED
Tobacco Smoking Among Crosslinked-keratoconus Patients
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Keratoconus
Eligibility:
All Genders
Brief Summary
Certain studies reported that cigarette by-products may make the cornea more rigid, suggesting that it could lead to "natural" CXL of collagen fibers, hence a protective effect for KC. Others have rep...
Detailed Description
a telephone Survey was performed among 80 KC patients who were treated from March 2014 until September 2017 by accelerated crosslinking (A-CXL) within the ophthalmology department. From the 80 people ...
Eligibility Criteria
Inclusion
- patients suffering from Keratoconus and needing Cross-linking therapy
Exclusion
- none
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03462355
Start Date
March 1 2014
End Date
January 30 2018
Last Update
March 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.